Tissue Regenix Group plc (LON:TRX – Get Rating)’s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 0.58 ($0.01) and traded as high as GBX 0.65 ($0.01). Tissue Regenix Group shares last traded at GBX 0.64 ($0.01), with a volume of 5,769,508 shares.
Tissue Regenix Group Stock Up 1.6 %
The business’s 50-day moving average is GBX 0.64 and its 200-day moving average is GBX 0.58. The company has a market capitalization of £45.06 million, a price-to-earnings ratio of -6.35 and a beta of 1.51. The company has a quick ratio of 2.36, a current ratio of 4.63 and a debt-to-equity ratio of 27.60.
About Tissue Regenix Group
Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine in the United States and internationally. It operates through BioSurgery, Orthopaedics & Dental, and GBM-V & Cardiac divisions.
- META Platforms May See its Biggest Opening Yet for New Highs
- Penny Stock Vinco Ventures Could Be Big Winner
- Is Chip Design Specialist Synopsys A Gem Hiding In Plain Sight?
- Should You Park Some Capital with Casey’s General Stores?
- Crowdstrike Stock: While The Iron Is Hot!
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.